Universitat de Barcelona
2021-09-14T13:07:38Z
2022-07-31T05:10:18Z
2021-07
2021-09-14T13:07:38Z
Background Atopic dermatitis is a chronic inflammatory skin disease that has substantial effects on patients' quality of life, with a prevalence between 2.2% and 17.6% worldwide. This study aimed to evaluate the use of specialized care resources generated by children and adults with atopic dermatitis, and the associated direct medical costs. Methods Admission details from patients admitted in specialized healthcare centers (inpatient and outpatient care) in Spain between 1 January 2000 and 31 December 2017 were analyzed in a retrospective multicentre study (...)
Article
Accepted version
English
Dermatitis; Assistència sanitària; Anàlisi cost-benefici; Dermatitis; Medical care; Cost effectiveness
Informa Healthcare
Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2021.1823222
Expert Review of Pharmacoeconomics & Outcomes Research, 2021, vol. 21, num. 4, p. 737-742
https://doi.org/10.1080/14737167.2021.1823222
(c) Informa Healthcare, 2021
Economia [1045]
